Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 2/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PTAFR | P25105 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TNF | P01375 | 1/20 | 0.36 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12723040 | 1.00 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL17265729 | 1.00 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL5652692 | 1.00 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL14971389 | 1.00 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL15686649 | 1.00 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL4478966 | 1.00 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL3230862 | 1.00 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL10066970 | 1.00 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL3103625 | 1.00 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL14838314 | 1.00 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108841379-A | A kind of preparation method of the OLED hole transport new material suitable for solution processing | 刘坤 | 2018-11-20 | — | — | CN | claimed |
| CN-108841379-A | A kind of preparation method of the OLED hole transport new material suitable for solution processing | 刘坤 | 2018-11-20 | — | — | CN | disclosed |
| US-20130190399-A1 | Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA) | MARTEK BIOSCIENCES CORPORATION (US) | 2013-07-25 | — | — | US | disclosed |
| US-20130190399-A1 | Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA) | MARTEK BIOSCIENCES CORPORATION (US) | 2013-07-25 | — | — | US | disclosed |
| WO-2011053892-A1 | SYNTHESIS AND USE OF OMEGA-3 AND OMEGA-6 VERY LONG CHAIN POLYUNSATURATED FATTY ACIDS (VLC-PUFA) | MARTEK BIOSCIENCES CORPORATION (US) | 2011-05-05 | — | — | WO | disclosed |
| US-7425281-B2 | Liquid crystal compositions comprising an organogermanium compound and methods for using the same | DISPLAYTECH, INC. (US) | 2008-09-16 | — | — | US | disclosed |
| EP-0405391-A1 | Certain (arylsulfonamido- and pyridyl- or imidazolyl-)-substituted carboxylic acids and derivatives thereof | CIBA-GEIGY AG (CH) | 1991-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130190399-A1 | Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA) | ELOVL3, ELOVL6, ELOVL1 | MEN1 3371/4885KMT2A 3307/4885ALDH1A1 1711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.